Crestor Tops List of Best-Selling Drugs

View the Cholesterol Levels Slideshow Pictures

By Robert Lowes
WebMD Health News

Nov. 1, 2013 -- The cholesterol-lowering drug Crestor (rosuvastatin) was the nation's most prescribed drug in the past 12 months, according to a new report from research firm IMS Health. New prescriptions and refills of the drug totaled 23.7 million.

The report looks at the top 100 selling drugs in the U.S., by prescriptions and sales. It tracked data over a 12-month period through September.

On the sales side, the antipsychotic drug Abilify (aripiprazole) racked up the highest sales with nearly $6.4 billion. Abilify is prescribed to treat schizophrenia, depression, and bipolar disorder, plus other things.

The 10 top-selling drugs reflect little change since calendar year 2012, according to IMS Health.

Here are the top 10 drugs by number of prescriptions:

  1. Crestor: 23.7 million
  2. Synthroid: 23.4 million
  3. Nexium: 20.7 million
  4. Cymbalta: 19.4 million
  5. Ventolin HFA: 17.5 million
  6. Advair Diskus: 16.6 million
  7. Diovan: 13.1 million
  8. Vyvanse: 10.4 million
  9. Spiriva Handihaler: 9.6 million
  10. Lantus: 9.4 million

Here are the top 10 drugs by total sales:

  1. Abilify: $6.4 billion
  2. Nexium: $6 billion
  3. Cymbalta: $5.4 billion
  4. Humira: $5.4 billion
  5. Crestor: $5.3 billion
  6. Advair Diskus: $5.1 billion
  7. Enbrel: $4.7 billion
  8. Remicade: $4 billion
  9. Copaxone: $3.8 billion
  10. Neulasta: $3.5 billion

The complete list can be found on Medscape.

SOURCES: Medscape Medical News: "Top 100 Selling Drugs Through September Reported." WebMD Drug Reference from First DataBank: "Abilify."

©2013 WebMD, LLC. All Rights Reserved.

Subscribe to MedicineNet's Heart Health Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors